• Cancer Antigen (CA) 19-9, Pleural Fluid
  • Dopamine beta-hydroxylase (DBH) Genetic Variations
  • Guardant360 TissueNextâ„¢, Lung and Breast Cancer Therapy Management
  • Butabarbital, Urine
  • Aspergillus DNA, Qualitative, Real-Time PCR, Sputum
  • Dopamine D2L receptor (DRD2L) Antibody, IgG
  • Human Chorionic Gonadotropin (HCG), Qualitative, Serum
  • Bromazepam
  • HelioLiverâ„¢ Methylation Assay for Hepatocellular Carcinoma
  • Zika Virus IgM Antibody, IgM
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Breast Cancer Antigen CA 15-3
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Breast Cancer Antigen CA 15-3
Medical Test

Additional ICD10
Access to Breast Cancer Antigen CA 15-3 is restricted.